#45 HIV’s Rare Defenders: Elite Controllers & Non-Progressors in HIV

https://is1-ssl.mzstatic.com/image/thumb/Podcasts123/v4/43/60/89/436089a1-b469-42d9-3391-3e22f2066edc/mza_5227804812137127087.jpg/600x600bb.jpg

Sex Ed Bites

Abhishek Katiyar

57 episodes

3 days ago

Become a Paid Subscriber: https://podcasters.spotify.com/pod/show/sexedbites/subscribe Sex Ed bites is a podcast aiming to explore the facts and dispel the myths surrounding sex education. Our mission is to empower our listeners and increase awareness around sex Education around the globe

Sexuality

Health & Fitness

RSS

All content for Sex Ed Bites is the property of Abhishek Katiyar and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Sexuality

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/36343602/36343602-1673698922468-3611151d6ec03.jpg

#45 HIV’s Rare Defenders: Elite Controllers & Non-Progressors in HIV

Sex Ed Bites

9 minutes 25 seconds

1 year ago

#45 HIV’s Rare Defenders: Elite Controllers & Non-Progressors in HIV

Welcome to Episode 45 of the Sex Ed Bites Podcast, hosted by Abhishek, a seasoned pharmacist specializing in sexual health. This episode delves into a rare but intriguing aspect of HIV – the phenomenon of elite controllers and long-term non-progressors. These unique individuals possess the remarkable ability to manage HIV naturally, without relying on medication. In this enlightening episode, we explore the distinct characteristics of elite controllers and long-term non-progressors, who make up about 1% of the global HIV-positive population. Unlike the majority requiring antiretroviral therapy, these individuals maintain low viral loads or stable immune systems without pharmaceutical intervention. We discuss their significance in the HIV research landscape and the ongoing debate over whether they should undergo conventional HIV treatment. As we dissect this topic, we also touch upon the broader implications of HIV treatment and management, referencing back to Episode 22 for those seeking more in-depth information about HIV therapies. The discussion navigates through compelling arguments on both sides of the treatment debate, weighing the potential benefits and drawbacks of medicating this unique subset of the HIV-positive population. This episode not only provides an insightful analysis of these extraordinary cases but also sheds light on the advancements in personalized medicine in the realm of HIV. We aim to educate and spark curiosity about the complexities and nuances of HIV management, emphasizing the importance of informed and personalized healthcare choices. Join us on this journey of discovery and understanding. Share this episode with someone who might find it valuable, and don’t forget to follow us on Twitter @realsexedbites and @pharmIDexpert for more updates. We’re committed to making sex education a human right, and your support helps us reach a wider audience. Leave us a 5-star review on Apple Podcasts, Spotify, Google Podcasts, or wherever you’re tuning in, and stay tuned for more insightful discussions in upcoming episodes.